EUVIMEDEUVIMED entdecken
CrossrefInfokarte

SARS-CoV-2 and thyroid disease: a nationwide study on hyperthyroidism and hypothyroidism using Oracle EHR Real-World Data

Fares Qeadan, Benjamin Tingey, Jamie Egbert, Aisha Arshad, Trenton Honda

AJE Advances: Research in Epidemiology · 2025

DOI: 10.1093/ajeadv/uuaf006 ↗
AbstractBibliografische Angaben

Abstract

Abstract We investigate the risk of new-onset hyperthyroidism and hypothyroidism following COVID-19 in patients with no history of thyroid disease. Retrospective data consisting of 5 543 496 patients ≥18 years old, 1 847 832 patients with COVID-19 from December 2019 to August 2024 and 3 695 664 matched (2 to 1) patients without COVID-19 from January 2018 to August 2024, from the Oracle EHR Real-World Data, comprising all United States, were utilized. Incidence rates, incidence rate ratios, and adjusted hazard ratios (aHRs) for hyperthyroidism and hypothyroidism among those with COVID-19 compared to those without COVID-19 were calculated. COVID-19 was associated with a significantly higher risk of hyperthyroidism (aHR: 1.41; 95% CI: 1.36, 1.47) and hypothyroidism (aHR: 1.22; 95% CI: 1.20, 1.24). Patients with COVID-19 from outpatient encounters (hyper aHR: 1.32; hypo aHR: 1.18), non-hospitalized (hyper aHR: 1.45; hypo aHR: 1.29), hospitalized (hyper aHR: 1.55; hypo aHR: 1.31), transfered to the intensive care unit (hyper aHR: 1.57; hypo aHR: 1.49), ventilator dependent (hyper aHR: 3.05; hypo aHR: 2.19), and extracorporeal membrane oxygenation dependent (hyper aHR: 9.87; hypo aHR: 5.15) all had significantly higher risks of hyper/hypothyroidism than non-COVID-19 patients. Those with COVID-19 reinfection and long COVID-19 additionally had significantly higher risks of hyper/hypothyrdisim than COVID-19 patients without conditions and non-COVID-19 patients. Our findings identify, in the largest study to date, the impact of COVID-19 on the risk of thyroid disorders, and identify that COVID-19 severity and extended COVID-19 confer a particularly high thyroid disease risk.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →